We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Use of a Rapid Test to Diagnose Influenza in the Emergency Room Influences Choice of Treatment

By LabMedica International staff writers
Posted on 26 Nov 2013
An exhaustive retrospective study conducted in the United States found that patients tested for and diagnosed with influenza with a rapid test were more likely to receive appropriate treatment than those diagnosed with the flu without testing.

Investigators at the University of Utah (Salt Lake City, USA) reviewed data from the National Hospital Ambulatory Medical Care Survey, a nationally representative sample of emergency room visits in the US From this database they identified children and adults who had been diagnosed with influenza across three flu seasons (2007-2009).

Analysis of the data showed that 23% of patients diagnosed with influenza without rapid testing received a prescription for antibiotics, which are not effective in treating influenza. More...
However, only 11% patients who were diagnosed by rapid testing were given prescriptions for antibiotics. Additional laboratory tests, including chest X-rays, blood tests, and urinalysis were ordered less frequently for patients whose influenza illness was diagnosed with a rapid test.

Prescriptions for antiviral drugs, which can be effective in treating influenza when used early and appropriately, were ordered for 56% of patients diagnosed with influenza using a rapid test, compared to orders for prescriptions for antiviral drugs for only 19% of influenza patients diagnosed without testing.

Overall, the data showed that influenza diagnoses made in association with a rapid assay resulted in fewer additional tests, antibiotic prescriptions, and more frequent use of antiviral drugs. These findings suggest that results of rapid testing influence physician behavior.

"When results of influenza tests are available to physicians at the "point of care,” they use this information to provide more appropriate patient management," said senior author Dr. Anne J. Blaschke, associate professor of pediatrics at the University of Utah. "While other studies have shown that physicians can accurately diagnose influenza without testing, our results suggest that using an influenza test increases diagnostic certainty and leads to the physician providing more specific and appropriate care."

The study was published in the November 13, 2013, online edition of the Journal of the Pediatric Infectious Diseases Society.

Related Links:

University of Utah



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
High-Density Lipoprotein Containing Cholesterol Assay
HDL-c direct FS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.